<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>23 patients with primary <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> was observed in 1982-1988 </plain></SENT>
<SENT sid="1" pm="."><plain>8 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t according to FAB criterias were treated with low dose <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>No complete response and only one partial response +10 months duration was achieved </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment had a minor influence on the natural course of disease, and doesn't protect patients from the transformation into <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemias</z:mpath> </plain></SENT>
</text></document>